ReviewFrontiers in immunology2026
Refractory mastoiditis as the initial manifestation of granulomatosis with polyangiitis:a case report and literature review.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Granulomatosis with Polyangiitis (GPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis that predominantly affects the upper or lower respiratory tracts and the kidney. While otologic involvement is relatively common in GPA, isolated destructive mastoiditis as the initial manifestation is exceedingly rare, often leading to misdiagnosis. Case presentation: A 69-year-old female presented with a 3-months history of progressive bilateral hearing loss and otorrhea. Based on clinical and radiological findings, she was initially diagnosed with acute mastoiditis but showed no response to antibiotic therapy. She subsequently underwent right sided canal-wall-up mastoidectomy; however, postoperative symptoms persisted, and pathological examination only revealed inflammatory granulation tissue. Her condition further deteriorated, with the development of contralateral ear involvement and persistent low-grade fever. Serological testing eventually showed a proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) level>200 RU/mL and chest computed tomography (CT) demonstrated multiple bilateral pulmonary nodules. The patient was thus diagnosed with GPA and initiated on methylprednisolone pulse therapy, followed by rituximab (RTX). Conclusion: This case highlights that, in patients with refractory mastoiditis unresponsive to conventional antibiotics and surgical intervention, otolaryngologists should maintain a high index of suspicion for underlying systemic vasculitides and initiate early ANCA testing. Such measures are critical to avoid diagnostic delays and prevent irreversible organ damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.